Safety of live attenuated herpes zoster vaccine in Australian adults 70–79 years of age: an observational study using active surveillance

OBJECTIVES: To assess the safety of live attenuated herpes zoster vaccine live (ZVL) through cumulative analysis of near real-time, participant-based active surveillance from Australia’s AusVaxSafety system. DESIGN AND SETTING: ZVL was funded in Australia for adults aged 70 years from November 2016,...

Descripción completa

Detalles Bibliográficos
Autores principales: Phillips, Anastasia, Glover, Catherine, Leeb, Alan, Cashman, Patrick, Fathima, Parveen, Crawford, Nigel, Snelling, Thomas L, Durrheim, David, Macartney, Kristine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Public Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7996657/
https://www.ncbi.nlm.nih.gov/pubmed/33766842
http://dx.doi.org/10.1136/bmjopen-2020-043880

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7996657/
https://www.ncbi.nlm.nih.gov/pubmed/33766842
http://dx.doi.org/10.1136/bmjopen-2020-043880

Ejemplares similares